While Insys Therapeutics, which profited wildly from the sale of a powerful fentanyl spray known as Subsys, was under investigation by federal prosecutors for its marketing practices in 2015. At that time the company's founder, John Kapoor told then-CEO Michael Babich that Babich would be the one who was going to shoulder the blame -- according to Babich, who has pleaded guilty to one count of mail fraud and one count of conspiracy. He is now a key witness in the racketeering prosecution of Kapoor and four other former executives and sales directors.
from Kaiser Health News http://bit.ly/2GuHXzy
February 15, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Listen: Why Red States Challenging ACA Tread Precariously On A Popular ProtectionStates seeking to overturn the Affordable Care Act must do a delicate dance. That’s because most of them have higher-than-average rates of residents with preexisting conditions — a group specifically protected under the ACA. … Read More
Perspectives: We’re Already Seeing Results From Trump’s Drug Blueprint To Lower CostsRead recent commentaries about drug-cost issues. from Kaiser Health News https://ift.tt/2vs0THd … Read More
Drug Rebates’ Days Are Numbered, Pfizer CEO Says Of Latest Culprits In High Prices Blame GameNews outlets report on stories related to pharmaceutical pricing. from Kaiser Health News https://ift.tt/2LZ5nzL … Read More
Viewpoints: Lessons On Potential Costs Of Medicare-For-All Health Care System; Important Messages From Voters About Preexisting ConditionsOpinion writers about these and other health care issues. from Kaiser Health News https://ift.tt/2LTGGV7 … Read More
State Highlights: USC Faculty Pushes For President’s Ouster As Number Of Patients Suing University Ticks Up; Advocates Decry NYC Hospital’s Decision To Close Birthing CenterMedia outlets report on news from California, New York, Virginia, Texas, Massachusetts, Minnesota, Wisconsin and Kansas. from Kaiser Health News https://ift.tt/2vs0Riz … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment